Acromegaly guidelines: How useful are they?

January 28, 2015

 From Lewis S. Blevins, Jr. MD  –  Every few years, one organization or another releases “guidelines” and “recommendations” regarding the management of patients with acromegaly. These often include algorithms provided by an “acromegaly consensus group”

Pituitary blood flow

December 30, 2014

From Lewis S Blevins, Jr MD  –  The pituitary gland is certainly quite small, and not metabolically active when compared to other organs, thus commands a very small fraction of the cardiac output.  Pituitary blood

More on Residual Hyperprolactinemia.

November 30, 2014

From Lewis S Blevins Jr. MD  –  I am often asked how I approach those patients who have “residual hyperprolactinemia” after either surgery, and especially if there is no visible residual tumor on MRI, or

Pituitary Hyperplasia.

November 10, 2014

From Lewis S. Blevins Jr., MD  –  Hyperplasia is an increase in the number of cells in a tissue. The cells are related, in that they may be of the same cell type, but are

Acromegaly and Bone Disease

November 3, 2014

From Lewis S. Blevins, Jr., MD –  “This is a nice review highlighting bone disease in patients with acromegaly.  One would think that bone enlargement would be associated with increased strength. That is not always

TSH-Secreting Adenomas

October 29, 2014

From Lewis S Blevins Jr., MD  –  TSH-secreting (thyrotroph) adenomas are rare and account for less than 1% of all pituitary adenomas. They usually lead to excess production of thyroid hormone (hyperthyroidism), but can also